Hendrik Peter Nicolas Scholl
Affiliations: | 1997-2001 | Eberhard Karls Universität Tübingen, Tübingen, Baden-Württemberg, Germany | |
| 2001-2003 | Moorfields Eye Hospital | ||
| 2003-2010 | University of Bonn, Bonn, Nordrhein-Westfalen, Germany | ||
| 2010-2016 | Wilmer Eye Institute | Johns Hopkins University, Baltimore, MD | |
| 2016- | Department of ophthalmology | University of Basel, Basel, Basel-Stadt, Switzerland | |
| 2018- | Institute of Molecular and Clinical Ophthalmology Basel |
Google:
"Hendrik Scholl"Bio:
Scholl specializes in the medical and surgical treatment of retinal diseases such as age-related macular degeneration and diabetic retinopathy. His particular clinical and scientific focus is in the area of hereditary retinal and macular degeneration, using the latest technologies such as electroretinography, microperimetry and high-resolution imaging for diagnostics.
(Show more)
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Eberhart Zrenner | post-doc | Universität Tübingen | ||
| (Ophthalmology resident) | ||||
| Alan Charles Bird | post-doc | 2001-2003 | Moorfields Eye Hospital | |
| Frank Gerhard Holz | post-doc | 2004-2010 | University of Bonn, Germany | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bocquet B, Borday C, Erkilic N, et al. (2023) TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa. Jci Insight |
| Scholl HP, Strauss RW, Singh MS, et al. (2016) Emerging therapies for inherited retinal degeneration. Science Translational Medicine. 8: 368rv6 |
| Strauss RW, Ho A, Muñoz B, et al. (2016) The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. Ophthalmology. 123: 817-28 |
| Fritsche LG, Igl W, Bailey JN, et al. (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nature Genetics. 48: 134-43 |
| Scholl HP, Moore AT, Koenekoop RK, et al. (2015) Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT). Plos One. 10: e0143846 |
| Heeren TF, Clemons T, Scholl HP, et al. (2015) Progression of Vision Loss in Macular Telangiectasia Type 2. Investigative Ophthalmology & Visual Science. 56: 3905-12 |
| Charbel Issa P, Scholl HP, Holz FG. (2014) Short-term effects of intravitreal bevacizumab in type ii idiopathic macular telangiectasia. Retinal Cases & Brief Reports. 1: 189-91 |
| Chen C, Khurana RN, Scholl H, et al. (2014) Macular caldera in North Carolina macular dystrophy: only an illusion of posterior pole staphyloma. Jama Ophthalmology. 132: 786-7 |
| Ratnapriya R, Zhan X, Fariss RN, et al. (2014) Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration. Human Molecular Genetics. 23: 5827-37 |
| Fritsche LG, Chen W, Schu M, et al. (2013) Seven new loci associated with age-related macular degeneration. Nature Genetics. 45: 433-9, 439e1-2 |